 | |
| Clinical data | |
|---|---|
| Other names | 17α-Demethylstanozolol 17β-tetrahydropyran ether; 17β-[(Tetrahydro-2H-pyran-2-yl)oxy]-5α-androst-2-eno[3,2-c]pyrazole; [3,2-c]Pyrazole-5α-etioallocholane-17β-tetrahydropyranol; 17β-[(Tetrahydro-2H-pyran-2-yl)oxy]-2'H-5α-androst-2-eno[3,2-c]pyrazole; Pyrazolo[4',3':2,3]-5α-androstan-17β-ol 17β-tetrahydropyran ether |
| Routes of administration | By mouth |
| Drug class | Androgen;Anabolic steroid;Androgen ether |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C25H38N2O2 |
| Molar mass | 398.591 g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
Prostanozol, also known asdemethylstanozolol tetrahydropyran ether, is anandrogen/anabolic steroid (AAS) anddesigner steroid which acts as aprodrug of the 17α-demethylatedanalogue ofstanozolol (Winstrol). It was found in 2005 as an ingredient of products sold as "dietary supplements" forbodybuilding.[1]
It is one of hundreds of drugs banned from theOlympics by theIOC.[2]Russian marathon runnerLyubov Denisova was banned for two years from competition after testing positive for prostanozol and testosterone in 2007.[3]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
